Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: Possible neuroprotective mechanisms

European Journal of Pharmacology

Volumn 674, Issue 1, 2011, Pages 33-43

  Bhateja, Deepak Kumar ^a   Dhull, Dinesh K ^a   Gill, Aneet ^a   Sidhu, Akramdeep ^a   Sharma, Saurabh ^a   Reddy, B V Krishna ^a   Padi, Satyanarayana S V ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

3 nitropropionic acid; Fenofibrate; Huntington's disease; MK886; Oxidative stress

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 3 NITROPROPIONIC ACID; CARBONYL DERIVATIVE; CATALASE; FENOFIBRATE; GLUTATHIONE; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; NITRITE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; SUCCINATE DEHYDROGENASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; BRADYKINESIA; BRAIN HOMOGENATE; COGNITIVE DEFECT; CONTROLLED STUDY; COORDINATION DISORDER; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; DRUG MEGADOSE; ENZYME ACTIVITY; HUNTINGTON CHOREA; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; CATALASE; CYTOKINES; EXTREMITIES; FENOFIBRATE; GLUTATHIONE; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; MALE; MAZE LEARNING; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NITRITES; NITRO COMPOUNDS; OXIDATIVE STRESS; PPAR ALPHA; PROPIONIC ACIDS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; RETENTION (PSYCHOLOGY); SUCCINATE DEHYDROGENASE; SUPEROXIDE DISMUTASE;

EID: 82255175318     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.10.029     Document Type: Article

References (50)

1. M. Ahuja, M. Bishnoi, and K. Chopra Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity Toxicology 244 2008 111 122
2. M.F. Beal, E. Brouillet, B.G. Jenkins, R.J. Ferrante, N.W. Kowall, and J.M. Miller Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid J. Neurosci. 13 1993 4181 4192 (Pubitemid 23299942)
3. M.F. Beal, E. Brouillet, B.G. Jenkins, R.J. Ferrante, N.W. Kowall, and J.M. Miller 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic mice J. Neurochem. 65 1995 919 922
4. J. Beltowski, G. Wojcicka, M. Mydlarczyk, and A. Jamroz The effect of peroxisome proliferator-activated receptors α (PPARα) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON 1) activity J. Physiol. Pharmacol. 53 2002 463 475
5. A. Benani, P. Kremarik-Bouillaud, A. Bianchi, P. Netter, A. Minn, and M. Dauca Evidence for the presence of both peroxisome proliferator-activated receptors alpha and beta in the rat spinal cord J. Chem. Neuroanat. 25 2003 29 38 (Pubitemid 36164853)
6. A. Benani, T. Heurtaux, P. Netter, and A. Minn Activation of peroxisome proliferators-activated receptor alpha in rat spinal cord after peripheral noxious stimulation Neurosci. Lett. 369 2004 59 63 (Pubitemid 39369503)
7. V.C. Besson, X.R. Chen, M. Plotkine, and C. Marchand-Verrecchia Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury Neurosci. Lett. 388 2005 7 12 (Pubitemid 41569361)
8. E. Brouillet, C. Jacquard, N. Bizat, and D. Blum 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease J. Neurochem. 95 2005 1521 1540 (Pubitemid 41804051)
9. N. Bougarne, R. Paumelle, S. Caron, N. Hennuyer, R. Mansouri, and P. Gervois PPARalpha blocks glucocorticoid receptor alpha-mediated transactivation but cooperates with the activated glucocorticoid receptor alpha for transrepression on NF-kappaB Proc. Natl. Acad. Sci. USA 106 2009 7397 7402
10. X.R. Chen, V.C. Besson, B. Palmier, Y. Garcia, M. Plotkine, and C. Marchand-Leroux Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury J. Neurotrauma 24 2007 1119 1131 (Pubitemid 47106286)
11. M. Collino, M. Aragno, R. Mastrocola, E. Benetti, M. Gallicchio, and C. Dianzani Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-α agonist WY14643 Free Radic. Biol. Med. 41 2006 579 589 (Pubitemid 44080506)
12. B. Costa, S. Conti, G. Giagnoni, and M. Colleoni Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems Br. J. Pharmacol. 137 2002 413 420 (Pubitemid 35221894)
13. G. D'Agostino, G. La Rana, R. Russo, O. Sasso, A. Iacono, and E. Esposito Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice J. Pharmacol. Exp. Ther. 322 2007 1137 1143 (Pubitemid 47295805)
14. D. Deplanque, P. Gelé, O. Pétrault, I. Six, C. Furman, and M. Bouly Peroxisome proliferator-activated receptor-α activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment J. Neurosci. 23 2003 6264 6271 (Pubitemid 36875628)
15. E.A. Duckworth, T.K. Koutouzis, C.V. Borlongan, M.N. Gordon, A.E. Willing, and D.W. Cahill Rats receiving systemic 3-nitropropionic acid demonstrate impairment of memory in Morris water maze Psychobiology 27 1999 561 566 (Pubitemid 30075657)
16. G.L. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 1959 70 77
17. K. Fukui, K. Onodera, T. Shinkai, S. Suzuki, and S. Urano Impairment of learning and memory in rats caused by oxidative stress and aging, and changes in antioxidative defense systems Ann. N. Y. Acad. Sci. 928 2001 168 175 (Pubitemid 32386078)
18. D.S. Gelinas, and J. McLaurin PPAR-alpha expression inversely correlates with inflammatory cytokines IL-1beta and TNF-alpha in aging rats Neurochem. Res. 30 2005 1369 1375 (Pubitemid 41784472)
19. T. Genovese, E. Mazzon, R.D. Paola, G. Cannavo, C. Muia, and P. Bramanti Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma Exp. Neurol. 194 2005 267 278 (Pubitemid 40719761)
20. 15N] nitrate in biological fluids Ann. Biochem. 126 1982 131 138 (Pubitemid 13203451)
21. M.T. Heneka, and G.E. Landreth PPARs in the brain Biochim. Biophys. Acta 1771 2007 1031 1045 (Pubitemid 47208548)
22. 2 + superoxide dismutase and decrease p22phox message expressions in primary endothelial cells Metabolism 50 2001 3 11 (Pubitemid 32058541)
23. T. Kainu, A.C. Wikström, J.A. Gustafsson, and M. Pelto-Huikko Localization of the peroxisome proliferator-activated receptor in the brain Neuroreport 5 1994 2481 2485
24. A. Kreisler, P. Gelé, J.F. Wiart, M. Lhermitte, A. Destée, and R. Bordet Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not Brain Res. 1135 2007 77 84 (Pubitemid 46176827)
25. P. Kumar, S.S.V. Padi, P.S. Naidu, and A. Kumar Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms Behav. Pharmacol. 17 2006 485 492 (Pubitemid 44325810)
26. P. Kumar, S.S.V. Padi, P.S. Naidu, and A. Kumar Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity Methods Find Exp. Clin. Pharmacol. 29 2007 1 7
27. P. Kumar, S.S.V. Padi, P.S. Naidu, and A. Kumar Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms Fundam. Clin. Pharmacol. 21 2007 297 306 (Pubitemid 46800477)
28. P. Kumar, S.S.V. Padi, P.S. Naidu, and A. Kumar 3-Nitropropionic acid induced neurotoxicity: an animal model for Huntington's disease J. Cell Tissue Cult. 7 2007 853 860
29. M.A. La Fontaine, J.W. Geddes, A. Banks, and D.A. Butterfield Effect of exogenous and endogenous antioxidants on 3-nitropropionic acid-induced in vivo oxidative stress and striatal lesions: insights into Huntington's disease J. Neurochem. 75 2000 1709 1715
30. R. Lagoa, C. Lopez-Sanchez, A.K. Samhan-Arias, C.M. Gañan, V. Garcia-Martinez, and C. Gutierrez-Merino Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid J. Neurochem. 111 2009 473 487
31. R.L. Levine, D. Garland, C.N. Oliver, A. Amici, I. Climent, and A.G. Lenz Determination of carbonyl content in oxidatively modified proteins Methods Enzymol. 186 1990 464 478 (Pubitemid 20279989)
32. A.C. Ludolph, F. He, P.S. Spencer, J. Hammerstad, and M. Sabri 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin Can. J. Neurol. Sci. 18 1991 492 498
33. H.P. Misra, and I. Fridovich The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase J. Biol. Chem. 247 1972 3170 3175
34. S. Moreno, S. Farioli-Vecchioli, and M.P. Cerù Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS Neuroscience 123 2004 131 145 (Pubitemid 37518482)
35. M. Napolitano, D. Zei, D. Centonze, R. Palermo, G. Bernardi, A. Vacca, and P. Calabresi NF-κB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease Neurosci. Lett. 434 2008 241 246
36. N. Pavese, A. Gerhard, Y.F. Tai, A.K. Ho, F. Turkheimer, and R.A. Barker Microglial activation correlates with severity in Huntington disease: a clinical and PET study Neurology 66 2006 1638 1643 (Pubitemid 43964614)
37. V. Perez-De La Cruz, and A. Santamaria Integrative hypothesis for Huntington's disease: a brief review of experimental evidence Physiol. Res. 56 2007 513 526
38. J.K. Ryu, A. Nagai, J. Kim, M.C. Lee, J.G. McLarnon, and S.U. Kim Microglial activation and cell death induced by the mitochondrial toxin 3-nitropropionic acid: in vitro and in vivo studies Neurobiol. Dis. 12 2003 121 132 (Pubitemid 36349404)
39. D.A. Shear, J. Dong, C.D. Gundy, K.L. Haik-Creguer, and G.L. Dunbar Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease Prog Neuropsychopharmacol Biol. Psychiatry 22 1998 1217 1240 (Pubitemid 28511596)
40. A.K. Sinha Colorimetric assay of catalase Anal. Biochem. 47 1972 389 394
41. B. Staels, W. Koenig, A. Habib, R. Merval, M. Lebret, and I.P. Torra Activation of human aortic smooth-muscle cells is inhibited by PPAR but not by PPAR activators Nature 393 1998 790 793 (Pubitemid 28299490)
42. Y.F. Tai, N. Pavese, A. Gerhard, S.J. Tabrizi, R.A. Barker, and D.J. Brooks Imaging microglial activation in Huntington's disease Brain Res. Bull. 72 2007 148 151 (Pubitemid 46389550)
43. I. Tunez, P. Montilla, M. Munoz, M. Feijo, and M. Salcedo Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease J. Pineal Res. 37 2004 252 256 (Pubitemid 39457046)
44. I. Tunez, R.D. ColIn, I. Jimena, F.J. Medina, M. Munoz, and P. Montilla Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington's disease J. Neurochem. 97 2006 619 630
45. I. Tunez, J.A. Collado, F.J. Medina, J. Pena, M.C. Munoz, and I. Jimena 17 β-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats Neurochem. Intern. 48 2006 367 373 (Pubitemid 43327276)
46. J.C. Vis, M.M. Verbeek, R.M. Waal, H.J. Donkelaar, and H.P.H. Kremer 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum Neuropathol. Appl. Neurobiol. 25 1999 513 521 (Pubitemid 30045425)
47. J.C. Vis, R.T. de Boer-Van Huizen, M.M. Verbeek, R.M. de Waal, H.J. Donkelaar, and B. Kremer Creatine protects against 3-nitropropionic acid-induced cell death in murine corticostriatal slice cultures Brain Res. 1024 2004 16 24 (Pubitemid 39286712)
48. E.D. Wills Mechanism of lipid peroxide formation in animal Biochems. J. 99 1966 667 676
49. T.L. Yang, M.F. Chen, B.L. Luo, Q.Y. Xie, J.L. Jiang, and Y.J. Li Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity Naunyn Schmiedebergs Arch. Pharmacol. 371 2005 401 407
50. Z. Yu, D. Zhou, G. Cheng, and M.P. Mattson Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease J. Mol. Neurosci. 15 2000 31 44 (Pubitemid 32104603)